These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 3925465)
41. Synthesis and 5-lipoxygenase inhibitory activities of eicosanoid compounds. Arai Y; Shimoji K; Konno M; Konishi Y; Okuyama S; Iguchi S; Hayashi M; Miyamoto T; Toda M J Med Chem; 1983 Jan; 26(1):72-8. PubMed ID: 6298421 [TBL] [Abstract][Full Text] [Related]
42. Characterization of CGS 8515 as a selective 5-lipoxygenase inhibitor using in vitro and in vivo models. Ku EC; Raychaudhuri A; Ghai G; Kimble EF; Lee WH; Colombo C; Dotson R; Oglesby TD; Wasley JW Biochim Biophys Acta; 1988 Apr; 959(3):332-42. PubMed ID: 2833314 [TBL] [Abstract][Full Text] [Related]
43. Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1. Rauzi F; Kirkby NS; Edin ML; Whiteford J; Zeldin DC; Mitchell JA; Warner TD FASEB J; 2016 Dec; 30(12):4256-4266. PubMed ID: 27633788 [TBL] [Abstract][Full Text] [Related]
44. 12S-hydroxyeicosatetraenoic acid plays a central role in the regulation of platelet activation. Sekiya F; Takagi J; Usui T; Kawajiri K; Kobayashi Y; Sato F; Saito Y Biochem Biophys Res Commun; 1991 Aug; 179(1):345-51. PubMed ID: 1652954 [TBL] [Abstract][Full Text] [Related]
45. Inhibition by lipoxygenase products of TXA2-like responses of platelets and vascular smooth muscle. 14-Hydroxy from 22:6n-3 is more potent than 12-HETE. Croset M; Sala A; Folco G; Lagarde M Biochem Pharmacol; 1988 Apr; 37(7):1275-80. PubMed ID: 2965590 [TBL] [Abstract][Full Text] [Related]
46. Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. Kimura Y; Okuda H; Arichi S; Baba K; Kozawa M Biochim Biophys Acta; 1985 Apr; 834(2):224-9. PubMed ID: 3922420 [TBL] [Abstract][Full Text] [Related]
47. Albumin redirects platelet eicosanoid metabolism toward 12(S)-hydroxyeicosatetraenoic acid. Broekman MJ; Eiroa AM; Marcus AJ J Lipid Res; 1989 Dec; 30(12):1925-32. PubMed ID: 2621419 [TBL] [Abstract][Full Text] [Related]
48. Substrate down regulation of 12-lipoxygenase in human platelets. Dadaian M; Westlund P Adv Exp Med Biol; 2002; 507():113-6. PubMed ID: 12664573 [No Abstract] [Full Text] [Related]
49. Decreased arachidonic acid metabolism in human platelets by autologous neutrophils: possible role of cell adhesion. Chabannes B; Molière P; Pacheco Y; Lagarde M Biochem J; 1994 Jun; 300 ( Pt 3)(Pt 3):685-91. PubMed ID: 7516654 [TBL] [Abstract][Full Text] [Related]
50. Albumin modifies the metabolism of hydroxyeicosatetraenoic acids via 12-lipoxygenase in human platelets. Dadaian M; Westlund P J Lipid Res; 1999 May; 40(5):940-7. PubMed ID: 10224163 [TBL] [Abstract][Full Text] [Related]
51. Effects of sulfonylurea agents on platelet arachidonic acid metabolism; study on platelet homogenates. Satoh K; Ozaki Y; Yatomi Y; Kume S Biochem Pharmacol; 1994 Aug; 48(5):1053-5. PubMed ID: 8093094 [TBL] [Abstract][Full Text] [Related]
52. Formation of 11-hydroxyeicosatetraenoic acid and 15-hydroxyeicosatetraenoic acid in human umbilical arteries is catalyzed by cyclooxygenase. Setty BN; Stuart MJ; Walenga RW Biochim Biophys Acta; 1985 Mar; 833(3):484-94. PubMed ID: 3918580 [TBL] [Abstract][Full Text] [Related]
53. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Chen YQ; Duniec ZM; Liu B; Hagmann W; Gao X; Shimoji K; Marnett LJ; Johnson CR; Honn KV Cancer Res; 1994 Mar; 54(6):1574-9. PubMed ID: 7511046 [TBL] [Abstract][Full Text] [Related]
54. Inhibition of platelet thromboxane synthetase by sulfasalazine. Stenson WF; Lobos E Biochem Pharmacol; 1983 Jul; 32(14):2205-9. PubMed ID: 6135423 [TBL] [Abstract][Full Text] [Related]
55. Pharmacological characterization of the biosynthesis of prostanoids and hydroxyeicosatetraenoic acids in human whole blood and platelets by targeted chiral lipidomics analysis. Tacconelli S; Fullone R; Dovizio M; Pizzicoli G; Marschler S; Bruno A; Zucchelli M; Contursi A; Ballerini P; Patrignani P Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Dec; 1865(12):158804. PubMed ID: 32853794 [TBL] [Abstract][Full Text] [Related]
56. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets. Schafer AI; Turner NA; Handin RI Biochim Biophys Acta; 1982 Sep; 712(3):535-41. PubMed ID: 6812645 [TBL] [Abstract][Full Text] [Related]
57. A unique pool of free arachidonate serves as substrate for both cyclooxygenase and lipoxygenase in platelets. Chevy F; Wolf C; Colard O Lipids; 1991 Dec; 26(12):1080-5. PubMed ID: 1819690 [TBL] [Abstract][Full Text] [Related]
58. Effects of 9, 12, 15-octadecatrien-6-ynoic acid on the metabolism of arachidonic acid in platelets and on platelet aggregation. Guichardant M; Michel M; Borel C; Fay L; Magnolato D; Finot PA Thromb Res; 1992 Mar; 65(6):687-98. PubMed ID: 1636161 [TBL] [Abstract][Full Text] [Related]
59. 5-Hydroxyeicosanoids selectively stimulate the human neutrophil 15-lipoxygenase to use endogenous substrate. Nichols RC; Vanderhoek JY J Exp Med; 1990 Feb; 171(2):367-75. PubMed ID: 2154526 [TBL] [Abstract][Full Text] [Related]
60. Effects of reduced glutathione on the 12-lipoxygenase pathways in rat platelets. Chang WC; Nakao J; Orimo H; Murota S Biochem J; 1982 Mar; 202(3):771-6. PubMed ID: 6807297 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]